Skip to main content
Skip to footer

Dr. Hilde Vanaken

Sr. Industry Advisor, TCS Life Sciences and Healthcare

Decentralized Trials: Next Generation of Patient Centric Clinical Trials

The article measures the impact of the COVID-19 pandemic on traditional site-centric approach for clinical trials and advocates the adoption of modern technologies in clinical trials and symbiotic partnerships among all stakeholders to enable true patient centric clinical trials. It also highlights the role played by TCS ADD Life Sciences platform in enabling technology-led decentralized trials with a view to achieve patient centricity. 

Read the full article here: